| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Departments of Molecular Genetics (D.S.M., S.J., H.K.), Physiology and Biophysics (G.G.), and Medicine (R.D.K.), University of Illinois College of Medicine, Chicago, Illinois 60607; and National Hormone and Peptide Program (A.F.P.), Harbor-UCLA Medical Center, Research and Education Institute, Torrance, California 90509
Address all correspondence and requests for reprints to: Hiroaki Kiyokawa, M.D., Ph.D., Department of Molecular Genetics, University of Illinois College of Medicine, 900 South Ashland Avenue, M/C 669, Chicago, Illinois 60607-7170. E-mail: . kiyokawa{at}uic.edu
The lactotroph undergoes dynamic regulation of cell cycle progression during pregnancy, as well as throughout the development of the pituitary. We recently reported that female mice with targeted disruption of Cdk4, one of the G1-regulatory cyclin-dependent kinases, are unable to support embryo implantation because of defective progesterone secretion from the corpus luteum. In this study, we demonstrate that this phenotype is not attributable to a primary defect in the corpus luteum but is a consequence of defective prolactin (PRL) production caused by inappropriate development of the pituitary lactotroph population. Specifically, the pituitary of Cdk4-deficient mice is extremely hypoplastic. Lactotrophs and somatotrophs of prepubertal Cdk4-deficient mice were 80% decreased in number, relative to those in wild-type mice, whereas gonadotrophs were unaffected. Lactotrophs of Cdk4-deficient mice did not proliferate in response to estrogen administration, whereas estrogen could induce the expression of galanin, an estrogen-responsive factor required for lactotroph proliferation. The reduction in lactotroph numbers was reflected by markedly diminished serum PRL levels in both prepubertal and postcoital Cdk4-deficient mice. Administration of PRL, after mating, significantly increased serum progesterone levels and restored implantation in Cdk4-deficient female mice. These observations demonstrate that Cdk4 is required for normal proliferation of the lactotroph population.
This article has been cited by other articles:
![]() |
V. Quereda and M. Malumbres Cell cycle control of pituitary development and disease J. Mol. Endocrinol., February 1, 2009; 42(2): 75 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Macias, Y. Kim, P. L. Miliani de Marval, A. Klein-Szanto, and M. L. Rodriguez-Puebla Cdk2 Deficiency Decreases ras/CDK4-Dependent Malignant Progression, but Not myc-Induced Tumorigenesis Cancer Res., October 15, 2007; 67(20): 9713 - 9720. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Neganova, H. Al-Qassab, H. Heffron, C. Selman, A. I. Choudhury, S. J. Lingard, I. Diakonov, M. Patterson, M. Ghatei, S. R. Bloom, et al. Role of Central Nervous System and Ovarian Insulin Receptor Substrate 2 Signaling in Female Reproductive Function in the Mouse Biol Reprod, June 1, 2007; 76(6): 1045 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chesnokova, K. Kovacs, A.-V. Castro, S. Zonis, and S. Melmed Pituitary Hypoplasia in Pttg-/- Mice Is Protective for Rb+/- Pituitary Tumorigenesis Mol. Endocrinol., September 1, 2005; 19(9): 2371 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jirawatnotai, A. Aziyu, E. C. Osmundson, D. S. Moons, X. Zou, R. D. Kineman, and H. Kiyokawa Cdk4 Is Indispensable for Postnatal Proliferation of the Anterior Pituitary J. Biol. Chem., December 3, 2004; 279(49): 51100 - 51106. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sherr and J. M. Roberts Living with or without cyclins and cyclin-dependent kinases Genes & Dev., November 15, 2004; 18(22): 2699 - 2711. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Pei, F. Bai, T. Tsutsui, H. Kiyokawa, and Y. Xiong Genetic Evidence for Functional Dependency of p18Ink4c on Cdk4 Mol. Cell. Biol., August 1, 2004; 24(15): 6653 - 6664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jirawatnotai, D. S. Moons, C. O. Stocco, R. Franks, D. B. Hales, G. Gibori, and H. Kiyokawa The Cyclin-dependent Kinase Inhibitors p27Kip1 and p21Cip1 Cooperate to Restrict Proliferative Life Span in Differentiating Ovarian Cells J. Biol. Chem., May 2, 2003; 278(19): 17021 - 17027. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zou, D. Ray, A. Aziyu, K. Christov, A. D. Boiko, A. V. Gudkov, and H. Kiyokawa Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence Genes & Dev., November 15, 2002; 16(22): 2923 - 2934. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |